To better identify the expression level of PJA2 in CRC, we detected the mRNA and protein levels of PJA2 in samples from colorectal cancer patients: 100 samples for qPCR (CRC cohort), 18 cases for WB, and 50 samples for IHC (TMA cohort). Here, PJA2 is linked to colorectal carcinoma.